C57BL/6-Tnfrsf1btm1c(EUCOMM)Wtsi/Ics
Status | Available to order |
EMMA ID | EM:05925 |
International strain name | C57BL/6-Tnfrsf1btm1c(EUCOMM)Wtsi/Ics |
Alternative name | Tnfrsf1b tm1c |
Strain type | Targeted Mutant Strains : Conditional mutation |
Allele/Transgene symbol | Tnfrsf1btm1c(EUCOMM)Wtsi |
Gene/Transgene symbol | Tnfrsf1b |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | ICS, Institut Clinique de la Souris |
Provider affiliation | ICS, Institut Clinique de la Souris |
Genetic information | This line originates from the C57BL/6NTac-Tnfrsf1btm1a(EUCOMM)Wtsi/Ics (EMMA ID EM:04391) strain, after breeding with a flp recombinase deleter line, to convert the original targeted allele tm1a (knock-out first allele ) into a conditional allele tm1c. For further details on the construction of this clone see the relevant page at the IKMC portal. Removal of the targeting cassette using flp recombinase is required to convert the targeted tm1a into a conditional tm1c allele - more information on conversion to the b,c and d allele forms. Click here for more information on EUCOMM final vectors. |
Phenotypic information | Currently not available. Heterozygous Tnfrsf1b-tm1c are viable. |
Breeding history | For production of the Tnfrsf1b tm1c line, Tnfrsf1b tm1a mice were crossed with N6 C57BL/6NTac flp recombinase (i.e. backcrossed 6x with C57BL/6NTac mice; original background C57BL/6J) |
References | None available |
Homozygous fertile | not known |
Homozygous viable | not known |
Homozygous matings required | no |
Immunocompromised | not known |
Information from EMMA
Archiving centre | ICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Sézary syndrome / Orphanet_3162
- Classic mycosis fungoides / Orphanet_2584
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- abnormal sleep pattern / MGI
- abnormal immune system physiology / MGI
- increased inflammatory response / MGI
- lung inflammation / MGI
- increased skin papilloma incidence / MGI
- no abnormal phenotype detected / MGI
- abnormal blood gas level / MGI
- abnormal lung compliance / MGI
- decreased susceptibility to bacterial infection / MGI
- increased susceptibility to bacterial infection / MGI
- decreased systemic arterial blood pressure / MGI
- abnormal glutamate-mediated receptor currents / MGI
- increased susceptibility to experimental autoimmune encephalomyelitis / MGI
- decreased susceptibility to autoimmune diabetes / MGI
- increased susceptibility to parasitic infection / MGI
- decreased T cell proliferation / MGI
- homeostasis/metabolism phenotype / MGI
- respiratory system phenotype / MGI
- skeleton phenotype / MGI
- periinsulitis / MGI
- increased circulating tumor necrosis factor level / MGI
- decreased interferon-gamma secretion / MGI
- decreased interleukin-2 secretion / MGI
- microgliosis / MGI
- decreased susceptibility to dopaminergic neuron neurotoxicity / MGI
- impaired central nervous system regeneration / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).